Jen Petter

Jen Petter

Company: Arrakis Therapeutics

Job title: Founder and Chief Scientific Officer

Seminars:

Panel Discussion: From Theory to Reality: How to Target RNA Biology with Small Molecule Approaches 3:30 pm

• Explore successful methods and mechanisms for the targeting of RNA through small molecule compounds • How can we utilize industry achievements to aid progression into the clinic? • Identifying, evaluating, and overcoming key challenges to unleash the full therapeutic potential of the field • Investigating the benefits and disease applications of effective RNA targetingRead more

day: Day One

Examining Methodologies, Chemical Biology & Structural Dynamics to Target mRNA with Small Molecules 9:30 am

• Examining the facts for mRNA targeting • Understanding RNA structure and dynamics • Outline and discuss the importance of small molecules focusRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.